Results 1 to 10 of about 3,866 (172)

Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD8 T Cells in Immunity To Mycobacterium tuberculosis

open access: yesMBio, 2022
The cytotoxic granules of human NK and CD8 T cells contain the effector molecule granulysin. Although in vitro studies indicate that granulysin is bactericidal to Mycobacterium tuberculosis and human CD8 T cells restrict intracellular M.
Rujapak Sutiwisesak   +2 more
exaly   +3 more sources

Biology and clinical relevance of granulysin [PDF]

open access: yesTissue Antigens, 2009
AbstractGranulysin is a cytolytic and proinflammatory molecule first identified by a screen for genes expressed ‘late’ (3–5 days) after activation of human peripheral blood mononuclear cells. Granulysin is present in cytolytic granules of cytotoxic T lymphocytes and natural killer cells.
A M, Krensky, C, Clayberger
exaly   +3 more sources

Perforin and Granulysin-Mediated Cytotoxicity in Colorectal Cancer Patients [PDF]

open access: yesMedicina
Background and Objectives: The incidence of colorectal cancer (CRC) in developed Western countries is constantly growing. CRC represents the third most common cancer and the second leading cancer-related cause of death worldwide.
Ludvig Letica   +9 more
doaj   +2 more sources

Granulysin: A Novel Host Defense Molecule [PDF]

open access: yesAmerican Journal of Transplantation, 2005
Granulysin is a novel cationic molecule present in the granules of cytotoxic T lymphocytes and natural killer cells. Cytotoxic T lymphocytes have long been associated with graft destruction in transplant rejection. Recent studies implicate granulysin in cell-mediated cytotoxicity, chemoattraction, immune activation and as a potential diagnostic ...
Alan M, Krensky, Carol, Clayberger
exaly   +3 more sources

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin

open access: yesOncoImmunology, 2019
Granulysin is a protein present in the granules of human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, with cytolytic activity against microbes and tumors.
Rocio Navarro   +2 more
exaly   +2 more sources

Granulysin: The attractive side of a natural born killer [PDF]

open access: yesImmunology Letters, 2020
First discovered in the 1980's, granulysin has until recently been thought of solely as an effector molecule present within cytotoxic immune cell populations, and involved in the direct killing of pathogens and infected or transformed eukaryotic cells.
Sparrow, E, Bodman-Smith, MD
exaly   +4 more sources

Plasma granulysin concentrations and preeclampsia risk [PDF]

open access: yesClinical Biochemistry, 2006
Epidemiological, clinical and histological data suggest intriguing similarities between preeclampsia and graft-host-rejection. Granulysin, a novel biomarker of overall cellular immunity, is secreted by natural killer cells and cytotoxic T lymphocytes, which are associated with graft-host-rejection.
, Chunfang Qiu, Masatoshi Sakai
exaly   +3 more sources

Cytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus [PDF]

open access: yesBiomedicines
Objectives: Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by persistent inflammation. Reliable biomarkers for predicting disease reactivation are lacking.
Paola Santana-Sánchez   +8 more
doaj   +2 more sources

Granulysin

open access: yesBiochemical Pharmacology, 2000
Alan M Krensky, A M Krensky
exaly   +2 more sources

Pinus roxburghii Constituents Augment Human Lymphocytes Mediated Cytotoxicity Towards Cancer Cells [PDF]

open access: yesPharmaceutical Sciences, 2021
Background: Pinus roxburghii has been used in the Himalayan region as folkloric remedy while nothing is yet known about its immunomodulatory potential.
Henok Gullilat   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy